Advertisement

Index by author

May 01, 1994; Volume 269,Issue 2

  1. Agneter, E

    1. Behavior of mesocortical dopamine terminals during single and repetitive stimulation: comparison with nigrostriatal neurons.
      E Agneter, I S Hoffmann, E A Singer and L X Cubeddu
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 470-476;

  2. Aguayo, L G

    1. Dopamine inhibits a sustained calcium current through activation of alpha adrenergic receptors and a GTP-binding protein in adult rat sympathetic neurons.
      L G Aguayo and J Grossie
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 503-508;

  3. Akai, T

    1. Chronic pharmacological activities of the novel anxiolytic beta-carboline abecarnil in rats.
      M Ozawa, K Sugimachi, Y Nakada-Kometani, T Akai and M Yamaguchi
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 457-462;

  4. Akuzawa, S

    1. Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
      A Nishida, K Miyata, R Tsutsumi, H Yuki, S Akuzawa, A Kobayashi, T Kamato, H Ito, M Yamano and Y Katuyama
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 725-731;

  5. Alloatti, G

    1. Role of platelet-activating factor (PAF) in oxygen radical-induced cardiac dysfunction.
      G Alloatti, G Montrucchio and G Camussi
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 766-771;

  6. Appleby, S D

    1. Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499].
      J J Lynch, A A Wallace, R F Stupienski, E P Baskin, C M Beare, S D Appleby, J J Salata, N K Jurkiewicz, M C Sanguinetti and R B Stein
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 541-554;

  7. Avram, M J

    1. A recirculatory pharmacokinetic model describing the circulatory mixing, tissue distribution and elimination of antipyrine in dogs.
      T C Krejcie, T K Henthorn, C A Shanks and M J Avram
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 609-616;

  8. Baskin, E P

    1. Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499].
      J J Lynch, A A Wallace, R F Stupienski, E P Baskin, C M Beare, S D Appleby, J J Salata, N K Jurkiewicz, M C Sanguinetti and R B Stein
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 541-554;

  9. Battaglia, G

    1. Delayed decreases in brain 5-hydroxytryptamine2A/2C receptor density and function in male rat progeny following prenatal fluoxetine.
      T M Cabrera and G Battaglia
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 637-645;

  10. Beare, C M

    1. Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499].
      J J Lynch, A A Wallace, R F Stupienski, E P Baskin, C M Beare, S D Appleby, J J Salata, N K Jurkiewicz, M C Sanguinetti and R B Stein
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 541-554;
« Previous (Pages : 1 2 3 4 5 6 ... 26) Next »
Back to top

In this issue

Advertisement